Notice to Extend PAR-21-315 Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
May 10, 2024
Related Announcements
- August 20, 2021 - Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional). See NOFO PAR-21-315.
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
This Notice extends the due date and expiration date of PAR-21-315 Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) to allow for an additional application due date on September 27, 2024.
Application Due Dates | Review and Award Cycles | ||||
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
October 20, 2021 | October 20, 2021 | Not Applicable | March 2022 | May 2022 | July 2022 |
February 18, 2022 | February 18, 2022 | Not Applicable | July 2022 | October 2022 | December 2022 |
June 20, 2022 | June 20, 2022 | Not Applicable | November 2022 | January 2023 | April 2023 |
October 18, 2022 | October 18, 2022 | Not Applicable | March 2023 | May 2023 | July 2023 |
February 21, 2023 | February 21, 2023 | Not Applicable | July 2023 | October 2023 | December 2023 |
June 19, 2023 | June 19, 2023 | Not Applicable | November 2023 | January 2024 | April 2024 |
October 18, 2023 | October 18, 2023 | Not Applicable | March 2024 | May 2024 | July 2024 |
February 20, 2024 | February 20, 2024 | Not Applicable | July 2024 | October 2024 | December 2024 |
June 20, 2024 | June 20, 2024 | Not Applicable | November 2024 | January 2025 | April 2025 |
September 27, 2024 | September 27, 2024 | Not Applicable | February 2025 | May 2025 | July 2025 |
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration date: September 28, 2024.
All other aspects of the opportunity(ies) remain the same.
Inquiries
Please direct all inquiries to:
Nick Langhals, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: Blueprint-MedTech@nih.gov
and Human Services (HHS)
